InfuSystem Holdings (INFU) EBITDA Margin (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly EBITDA Margin came in at 4.72% in Q1 2026, up 294.0% YoY from 1.2% in Q1 2025, and down 53.95% on a QoQ basis from 10.25% in Q4 2025.
InfuSystem Holdings (INFU) EBITDA Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of EBITDA Margin data on file, last reported at 4.72% in Q1 2026.
- Quarterly EBITDA Margin rose 294.0% year-over-year to 4.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.05% (up 298.0% YoY) and the FY2025 annual result came in at 8.31%, up 320.0% from the prior year.
- EBITDA Margin fell to 4.72% in Q1 2026, from 10.25% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 10.49% in Q2 2025 to a low of 2.64% in Q1 2024.
- A 5-year average of 4.48% and a median of 3.93% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin slumped 553 bps — and 2025, when it jumped 499 bps.
- Tracing INFU's EBITDA Margin over 5 years: stood at 3.57% in 2022, then climbed by 10 bps to 3.93% in 2023, then jumped by 96 bps to 7.73% in 2024, then surged by 33 bps to 10.25% in 2025, then slumped by 54 bps to 4.72% in 2026.
- The last three EBITDA Margin figures came in at 4.72% (Q1 2026), 10.25% (Q4 2025), and 10.44% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn | 11.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.24% |
| Mar 31, 2026 | 4.72% |
| Dec 31, 2025 | 10.25% |
| Sep 30, 2025 | 10.44% |
| Jun 30, 2025 | 10.49% |
| Mar 31, 2025 | 1.78% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | 9.24% |
| Jun 30, 2024 | 5.50% |
| Mar 31, 2024 | -2.64% |
| Dec 31, 2023 | 3.93% |
| Sep 30, 2023 | 5.32% |
| Jun 30, 2023 | 3.93% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | 3.57% |
| Sep 30, 2022 | 3.46% |
| Jun 30, 2022 | 0.77% |
| Mar 31, 2022 | -1.96% |
| Dec 31, 2021 | 6.04% |
| Sep 30, 2021 | -1.32% |